NL-OMON39655已完成3 期
Towards a better trauma treatment for older adults: From comparative research to actual implementation. - NET WITH OLDER ADULTS
Stichting Centrum 45 (Oegstgeest)0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients of Foundation Centrum '45 and Sinai Centre, older than 55 years of age,
- •with a DSM-IV classification of (full or subthreshold) Post Traumatic Stress Disorder
- •and a treatment indication of individual outpatient trauma focused Psychotherapy, without the need for assistance of interpreters
排除标准
- •Substance dependence
- •Remittance of substance dependence should be at least 3 months;
- •Psychotic disorder
- •Current manic or bipolar disorder
- •Severe depressive disorder (with suicidal or psychotic symptoms)
- •Cognitive impairments or cognitive disorder;
研究者
相似试验
招募中
不适用
ET with older adults.NOVO: NET Onderzoek Voor ouderen.Post Traumatic Stress Disorder (PTSD) with older adults (> 55 years of age).Posttraumatische stressstoornis (PTSS) bij ouderen (55+).NL-OMON26535Foundation Centrum '45Rijnzichtweg 35, 2342 AX OegstgeestandNienoord 5, 1112 XE Diemen80
进行中（未招募）
Unknown
Trauma-focused therapy for older adults: A clinical case seriesTrauma-focused therapies to reduce post-traumatic stress symptomsMental and Behavioural DisordersISRCTN51593856niversity of Manchester6
进行中（未招募）
不适用
Curative and palliative treatment of adults aged > 60 years with AML.A randomised trial by OSHO on the role of (1) early intensification {OSHO protocol} vs. common standard arm of German AML Intergroup Study, (2) allografting as consolidative immunotherapy vs. a second consolidation course in elderly patients,(3) prospective evaluation of the decision between curative and palliative treatment-intention. - AML 2004 OSHO #069Acute myelogenous leukemiaEUCTR2005-002833-10-ATGerman Competence network Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a330
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002272-27-ATSaarland University388